CEESAY ABRAHAM (Chief Executive Officer) sold 0.5% of their position (2.21K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $64.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/23/2026ACC: 0001193125-26-430504
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-2.21K
Net shares
Net seller
$64.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.21K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.21K
Price / share
$29.16
Trade value
$64.45K
% of position
0.5%
10/21/2026
452.25K→450.04K
Total
Net shares
−2.21K
Net value
-$64.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/21/2026 | S · Sale | −2.21K | $29.16 | $64.45K | 0.5% | 452.25K | 450.04K |
| Total | −2.21K | -$64.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported